These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
83 related items for PubMed ID: 1290306
1. On the role of Ca++ binding proteins as possible targets for Ca++ sensitizing agents. Herzig JW, Quast U. Z Kardiol; 1992; 81 Suppl 4():49-55. PubMed ID: 1290306 [Abstract] [Full Text] [Related]
2. Stimulation of cardiac myofilament force, ATPase activity and troponin C Ca++ binding by bepridil. Solaro RJ, Bousquet P, Johnson JD. J Pharmacol Exp Ther; 1986 Aug; 238(2):502-7. PubMed ID: 2942677 [Abstract] [Full Text] [Related]
3. Pharmacological modulation of cardiac and vascular contractile protein function. Silver PJ. J Cardiovasc Pharmacol; 1986 Aug; 8 Suppl 9():S34-46. PubMed ID: 2433541 [Abstract] [Full Text] [Related]
4. Potent stimulation of myofilament force and adenosine triphosphatase activity of canine cardiac muscle through a direct enhancement of troponin C Ca++ binding by MCI-154, a novel cardiotonic agent. Kitada Y, Kobayashi M, Narimatsu A, Ohizumi Y. J Pharmacol Exp Ther; 1989 Jul; 250(1):272-7. PubMed ID: 2545860 [Abstract] [Full Text] [Related]
5. A model for human cardiac troponin C and for modulation of its Ca2+ affinity by drugs. Ovaska M, Taskinen J. Proteins; 1991 Jul; 11(2):79-94. PubMed ID: 1946346 [Abstract] [Full Text] [Related]
6. Effects of new inotropic agents on Ca++ sensitivity of contractile proteins. Rüegg JC. Circulation; 1986 Mar; 73(3 Pt 2):III78-84. PubMed ID: 2935329 [Abstract] [Full Text] [Related]
7. Pharmacology of the bipyridines: amrinone and milrinone. Alousi AA, Johnson DC. Circulation; 1986 Mar; 73(3 Pt 2):III10-24. PubMed ID: 2417744 [Abstract] [Full Text] [Related]
8. Levosimendan, a calcium sensitizer in cardiac muscle, induces relaxation in coronary smooth muscle through calcium desensitization. Bowman P, Haikala H, Paul RJ. J Pharmacol Exp Ther; 1999 Jan; 288(1):316-25. PubMed ID: 9862786 [Abstract] [Full Text] [Related]
9. Drug interaction with cardiac and skeletal muscle troponin C. Geguchadze RN, Krylatov AV, Gusev NB. Biomed Sci; 1990 Jan; 1(1):37-42. PubMed ID: 2130916 [Abstract] [Full Text] [Related]
10. Effects of new inotropic agents on cyclic nucleotide metabolism and calcium transients in canine ventricular muscle. Endoh M, Yanagisawa T, Taira N, Blinks JR. Circulation; 1986 Mar; 73(3 Pt 2):III117-33. PubMed ID: 2417745 [Abstract] [Full Text] [Related]
11. Xestoquinone, a novel cardiotonic agent activates actomyosin ATPase to enhance contractility of skinned cardiac or skeletal muscle fibers. Kobayashi M, Muroyama A, Nakamura H, Kobayashi J, Ohizumi Y. J Pharmacol Exp Ther; 1991 Apr; 257(1):90-4. PubMed ID: 1826930 [Abstract] [Full Text] [Related]
12. Different effect of the Ca(2+) sensitizers EMD 57033 and CGP 48506 on cross-bridge cycling in human myocardium. Brixius K, Mehlhorn U, Bloch W, Schwinger RH. J Pharmacol Exp Ther; 2000 Dec; 295(3):1284-90. PubMed ID: 11082466 [Abstract] [Full Text] [Related]
13. Increase in Ca++ sensitivity of the contractile system by MCI-154, a novel cardiotonic agent, in chemically skinned fibers from the guinea pig papillary muscles. Kitada Y, Narimatsu A, Matsumura N, Endo M. J Pharmacol Exp Ther; 1987 Nov; 243(2):633-8. PubMed ID: 3500301 [Abstract] [Full Text] [Related]
17. The inotropic effects of amrinone and milrinone on neonatal and young canine cardiac muscle. Binah O, Sodowick B, Vulliemoz Y, Danilo P, Rosen M. Circulation; 1986 Mar; 73(3 Pt 2):III46-51. PubMed ID: 3002663 [Abstract] [Full Text] [Related]